TSCO
49
-2
AEE
60
-3
EXPD
48
5
MAR
69
-3
LNC
43
-2
LH
46
-4
FE
41
-3
EL
20
2
ORCL
68
-3
NWL
50
-6
V
66
-4
ETR
65
-3
XRAY
23
3
INTC
39
-10
UPS
48
-2
EQR
53
-7
KSS
46
4
AIZ
80
2
CTAS
56
-8
M
36
5
TSCO
49
-2
AEE
60
-3
EXPD
48
5
MAR
69
-3
LNC
43
-2
LH
46
-4
FE
41
-3
EL
20
2
ORCL
68
-3
NWL
50
-6
V
66
-4
ETR
65
-3
XRAY
23
3
INTC
39
-10
UPS
48
-2
EQR
53
-7
KSS
46
4
AIZ
80
2
CTAS
56
-8
M
36
5
Financhill
Back

EyePoint Pharmaceuticals Vs. Editas Medicine Industry Stock Comparison

Buy
69

EYPT
EyePoint Pharmaceuticals

Last Price:
9.19
Seasonality Move:
27.28%
Sell
43

EDIT
Editas Medicine

Last Price:
2.67
Seasonality Move:
16.26%
Buy
69
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $10.49. The Score for EYPT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.77. The Score for EDIT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $10.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.44 Buy
Relative Strength Index (14 RSI): 47.57 Sell
Chaikin Money Flow: -153416 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.83 - 11.91) Sell
Bollinger Bands (100): (8.07 - 10.47) Buy

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 38.08 Sell
Chaikin Money Flow: -1545182 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.95 - 3.37) Sell
Bollinger Bands (100): (3.16 - 4.84) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.41 Sell
20-day SMA: 11.17 Sell
50-day SMA: 9.65 Buy
200-day SMA: 14.13 Sell
8-day EMA: 11.18 Sell
20-day EMA: 10.96 Sell
50-day EMA: 10.2 Buy
200-day EMA: 11.62 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.1 Sell
20-day SMA: 3.14 Sell
50-day SMA: 3.35 Sell
200-day SMA: 5.35 Sell
8-day EMA: 3.03 Sell
20-day EMA: 3.12 Sell
50-day EMA: 3.4 Sell
200-day EMA: 5.13 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.36 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):